Please use this identifier to cite or link to this item:
http://elibrary.nnra.gov.ng/jspui/handle/123456789/684
Title: | Production Qualilty Control And Clinical Applications Of Radiosynovectomy Agents |
Authors: | IAEA |
Keywords: | Radiopharmaceuticals Synovectomy Nuclear medicine. Radioisotopes — Therapeutic use |
Issue Date: | 2021 |
Publisher: | NNRA Library |
Series/Report no.: | NO-3; |
Description: | Therapeutic radiopharmaceuticals play a major role in today’s nuclear medicine, especially in the treatment of cancer. They have long been applied in ‘radiation synovectomy’, or, more briefly, ‘radiosynovectomy’ (RSV). In recent decades, the production and quality control of radiopharmaceuticals for use in RSV has moved from simple 32P colloids to recently developed matrixes labelled with short and medium range beta emitters. RSV is a well established technique with growing applications worldwide. However, the lack of generic and peer reviewed production, quality control and clinical application guidelines and recommendations is a major concern for their application in human patients. |
URI: | http://elibrary.nnra.gov.ng/jspui/handle/123456789/684 |
Appears in Collections: | Human Health |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
PRODUCTION, QUALITY CONTROL AND CLINICAL APPLICATIONS OF RADIOSYNOVECTOMY AGENTS.pdf | 5.62 MB | Adobe PDF | View/Open |
Items in e-Library are protected by copyright, with all rights reserved, unless otherwise indicated.